Skip to main content
. Author manuscript; available in PMC: 2012 Dec 9.
Published in final edited form as: Lancet Oncol. 2010 Apr 29;11(6):561–570. doi: 10.1016/S1470-2045(10)70071-1

Figure 2. Trial profile.

Figure 2

EIA=etoposide+ifosfamide+doxorubicin. RHT=regional hyperthermia. STS=soft-tissue sarcoma. *Four patients in the combined therapy group and five patients in the EIA-alone group did not recevive EIA.